For more information or confidential assistance
se habla español

Benicar Lawsuits May be Centralized Under MDL

As Benicar lawsuits continue to escalate across the nation, plaintiffs have petitioned the Judicial Panel on Multidistrict Litigation (JPML) to consolidate similar actions that allege severe gastrointestinal injuries. In a motion filed on December 18, plaintiff Annette Johnson asked the JPML to transfer all federally-filed cases to the Northern District... Read more »

Study Shows Benicar Linked to Severe Abdominal Problems

The popular blood pressure drug known as Benicar (olmesartan medoxomil) is becoming increasingly known for its propensity to cause users severe and debilitating abdominal discomfort – reportedly linked to the onset of a condition known as sprue-like enteropathy. Benicar belongs to a class of drugs known as angiotensin receptor blockers,... Read more »

Research Sheds Light on Benicar Side Effects and Diabetes Risk

Benicar label
Angiotensin II type 1 receptor blockers (ARBs) are commonly used in the treatment of hypertension (high blood pressure) and heart failure. Benicar, manufactured by Daiichi Sankyo, is one of the more widely prescribed ARBs since its FDA approval in 2002. Also known by its generic name olmesartan medoxomil, Benicar has... Read more »

Study Finds Link Between Benicar and Celiac Like Symptoms

Benicar label
Celiac disease has been mysteriously on the rise in recent years but a new study has linked some celiac-like symptoms with the use of olmesartan, a popular blood pressure medication commonly sold under the name Benicar. Benicar is a hypertension medication also known under the generic name olmesartan. It is an angiotensin II receptor... Read more »